Literature DB >> 9797506

Interleukin-12 suppresses filaria-induced pulmonary eosinophilia, deposition of major basic protein and airway hyperresponsiveness.

R K Mehlotra1, L R Hall, A W Higgins, I A Dreshaj, M A Haxhiu, J W Kazura, E Pearlman.   

Abstract

Tropical Pulmonary Eosinophilia (TPE) is a severe form of allergic asthma caused by the host inflammatory response to filarial helminths in the lung microvasculature, and is characterized by pulmonary eosinophilia, increased filarial-specific IgG and IgE antibodies, and airway hyperresponsiveness. The current study examined the effect of IL-12 on pulmonary eosinophilia, deposition of eosinophil major basic protein and airway hyperresponsiveness in mice inoculated i.v. with Brugia malayi microfilariae. Injection of recombinant murine IL-12 modulated the T helper (Th) response in the lungs from Th2- to Th1-like, with elevated IFN-gamma, and decreased IL-4 and IL-5 production. Consistent with this shift in cytokine response, antigen-specific IgG2a was elevated, and IgG1 and total serum IgE were decreased. In addition, eosinophils in BAL fluid from IL-12 treated mice were reduced from 56% to 11%, and there was no detectable MBP on respiratory epithelial cells. Importantly, IL-12 suppressed airway hyperresponsiveness compared with saline-injected control animals. Taken together, these data clearly demonstrate that by modulating Th associated cytokine production, IL-12 down-regulates filaria-induced lung immunopathology.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9797506      PMCID: PMC4469192          DOI: 10.1046/j.1365-3024.1998.00174.x

Source DB:  PubMed          Journal:  Parasite Immunol        ISSN: 0141-9838            Impact factor:   2.280


  31 in total

1.  Induction of Th1 cell-mediated protective immunity to Schistosoma mansoni by co-administration of larval antigens and IL-12 as an adjuvant.

Authors:  A P Mountford; S Anderson; R A Wilson
Journal:  J Immunol       Date:  1996-06-15       Impact factor: 5.422

2.  Mucosal IFN-gamma gene transfer inhibits pulmonary allergic responses in mice.

Authors:  X M Li; R K Chopra; T Y Chou; B H Schofield; M Wills-Karp; S K Huang
Journal:  J Immunol       Date:  1996-10-15       Impact factor: 5.422

Review 3.  Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity.

Authors:  G Trinchieri
Journal:  Annu Rev Immunol       Date:  1995       Impact factor: 28.527

4.  The BALB/c mouse as a model for immunological studies of microfilariae-induced pulmonary eosinophilia.

Authors:  T G Egwang; J W Kazura
Journal:  Am J Trop Med Hyg       Date:  1990-07       Impact factor: 2.345

5.  Interleukin-12 prevents antigen-induced eosinophil recruitment into mouse airways.

Authors:  I Iwamoto; K Kumano; M Kasai; K Kurasawa; A Nakao
Journal:  Am J Respir Crit Care Med       Date:  1996-11       Impact factor: 21.405

6.  An isometric method to study respiratory smooth muscle responses in mice.

Authors:  J Garssen; H Van Loveren; H Van Der Vliet; F P Nijkamp
Journal:  J Pharmacol Methods       Date:  1990-11

7.  IL-12 inhibits Th2 cytokine responses induced by eggs of Schistosoma mansoni.

Authors:  I P Oswald; P Caspar; D Jankovic; T A Wynn; E J Pearce; A Sher
Journal:  J Immunol       Date:  1994-08-15       Impact factor: 5.422

8.  Elevated levels of the eosinophil granule major basic protein in the sputum of patients with bronchial asthma.

Authors:  E Frigas; D A Loegering; G O Solley; G M Farrow; G J Gleich
Journal:  Mayo Clin Proc       Date:  1981-06       Impact factor: 7.616

9.  Interleukin 12 inhibits antigen-induced airway hyperresponsiveness, inflammation, and Th2 cytokine expression in mice.

Authors:  S H Gavett; D J O'Hearn; X Li; S K Huang; F D Finkelman; M Wills-Karp
Journal:  J Exp Med       Date:  1995-11-01       Impact factor: 14.307

10.  Interleukin 4 and T helper type 2 cells are required for development of experimental onchocercal keratitis (river blindness).

Authors:  E Pearlman; J H Lass; D S Bardenstein; M Kopf; F E Hazlett; E Diaconu; J W Kazura
Journal:  J Exp Med       Date:  1995-10-01       Impact factor: 14.307

View more
  7 in total

Review 1.  The Regulatory Function of Eosinophils.

Authors:  Ting Wen; Marc E Rothenberg
Journal:  Microbiol Spectr       Date:  2016-10

2.  Histopathological analysis of initial cellular response in TLR-2 deficient mice experimentally infected by Leishmania (L.) amazonensis.

Authors:  Camila Silva Guerra; Roger Magno Macedo Silva; Luís Otávio Pereira Carvalho; Kátia da Silva Calabrese; Patrícia Torres Bozza; Suzana Côrte-Real
Journal:  Int J Exp Pathol       Date:  2010-10       Impact factor: 1.925

3.  Reciprocal immunomodulatory effects of gamma interferon and interleukin-4 on filaria-induced airway hyperresponsiveness.

Authors:  R K Mehlotra; L R Hall; M A Haxhiu; E Pearlman
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

4.  Wolbachia-induced neutrophil activation in a mouse model of ocular onchocerciasis (river blindness).

Authors:  Illona Gillette-Ferguson; Amy G Hise; Helen F McGarry; Joseph Turner; Andrew Esposito; Yan Sun; Eugenia Diaconu; Mark J Taylor; Eric Pearlman
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

5.  IL-4 receptor dependent expansion of lung CD169+ macrophages in microfilaria-driven inflammation.

Authors:  Frédéric Fercoq; Estelle Remion; Stefan J Frohberger; Nathaly Vallarino-Lhermitte; Achim Hoerauf; John Le Quesne; Frédéric Landmann; Marc P Hübner; Leo M Carlin; Coralie Martin
Journal:  PLoS Negl Trop Dis       Date:  2019-08-30

Review 6.  The Tumor Microenvironment: A Milieu Hindering and Obstructing Antitumor Immune Responses.

Authors:  Alireza Labani-Motlagh; Mehrnoush Ashja-Mahdavi; Angelica Loskog
Journal:  Front Immunol       Date:  2020-05-15       Impact factor: 7.561

Review 7.  The role of helminths in the development of non-communicable diseases.

Authors:  Yifan Wu; Megan Duffey; Saira Elizabeth Alex; Charlie Suarez-Reyes; Eva H Clark; Jill E Weatherhead
Journal:  Front Immunol       Date:  2022-08-31       Impact factor: 8.786

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.